Now showing items 1-1 of 1
DNA Real Estate: The Myriad Genetics Case and the Implications of Granting Patent Eligibility to Complimentary DNA
(Northern Illinois University Law Review, 2014-09)
In June 2013, in Ass’n for Molecular Pathology et. al., v. Myriad Genetics, Inc., the Supreme Court examined the patent eligibility of isolated (human) DNA and its components. This was in response to advances in breast ...